Page last updated: 2024-09-03

kallidin, des-arg(10)- and angiotensin ii

kallidin, des-arg(10)- has been researched along with angiotensin ii in 1 studies

Compound Research Comparison

Studies
(kallidin, des-arg(10)-)
Trials
(kallidin, des-arg(10)-)
Recent Studies (post-2010)
(kallidin, des-arg(10)-)
Studies
(angiotensin ii)
Trials
(angiotensin ii)
Recent Studies (post-2010) (angiotensin ii)
8041738,1521,0897,413

Protein Interaction Comparison

ProteinTaxonomykallidin, des-arg(10)- (IC50)angiotensin ii (IC50)
Atrial natriuretic peptide receptor 3Homo sapiens (human)0.002
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)0.002
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)0.0018
Type-1 angiotensin II receptorHomo sapiens (human)0.0055
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.004
Type-2 angiotensin II receptorHomo sapiens (human)0.0011

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adam, A; Bawolak, MT; Fortin, JP; Marceau, F; Vogel, LK1

Other Studies

1 other study(ies) available for kallidin, des-arg(10)- and angiotensin ii

ArticleYear
The bradykinin B2 receptor antagonist icatibant (Hoe 140) blocks aminopeptidase N at micromolar concentrations: off-target alterations of signaling mediated by the bradykinin B1 and angiotensin receptors.
    European journal of pharmacology, 2006, Dec-03, Volume: 551, Issue:1-3

    Topics: Angiotensin II; Angiotensin III; Aniline Compounds; Animals; Aorta; Bradykinin; Bradykinin B2 Receptor Antagonists; CD13 Antigens; Dose-Response Relationship, Drug; In Vitro Techniques; Kallidin; Kinetics; Protease Inhibitors; Quinolines; Rabbits; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Receptors, Angiotensin; Recombinant Proteins; Signal Transduction; Vasoconstriction; Vasoconstrictor Agents

2006